Novel Prescribing and Reimbursement Platform Launched

OrthogenRx launched an interesting and novel patient-centric prescribing and reimbursement platform at the recently concluded AAOS annual meeting.  This new, software-driven program allows patients with painful, arthritic knees to readily access viscosupplementation products as well as navigate the prior authorization forms for insurance specific plans and undertake benefits investigations.

Any patient, regardless of insurance status, can access the full range of OrthogenRx’s knee OA products by using this Doylestown, Pennsylvania company’s HARMOKNEE™ Customer Support Service program.

OrthogenRx, well known for its HA viscosupplementation products TriVix and GenVix 850, provides solutions to patients contending with knee osteoarthritis (OA) and are looking for joint lubrication and cushioning and for whom conservative non-pharmacologic therapy and analgesics such as acetaminophen has failed.

According to the company, TriVisc^® and GenVisc^®850 make OrthogenRx “the only company in the U.S. with both a non-avian three and five-injection regimen option.”

Significant Savings and Customer Service – Direct from the Manufacturer

Customers are offered a Direct Purchase option that opens the way for significant savings and provides a “dedicated customer support team works in lockstep to help ensure patients get the pain relief they need.”

Describing their Eureka! moment was Ashley Wohl, VP of marketing, who told OTW, “In Q4 2020, during our annual strategy planning we listed all the services OrthogenRx had developed over the years. A light bulb went on, we realized we had multiple service offerings that were disjointed and needed to be tied together under one brand. That brand is HARMONKEE™—Making the treatment of pain due to knee OA simple. While we OrthogenRx did not start out with a vision to create a branded suite of customer service offerings, by putting patients first, we consistently tend to end in a better place.”

“We took notice of the increasing number of patients who have limited (underinsured) or no access (uninsured) to a safe and efficacious class of products for the treatment of their chronic knee pain. We felt the need to intercede to ensure healthcare professionals and patients, have continued to have access to our products. The development and refinements we made on our Direct Purchase Program was a huge milestone. The Direct Purchase Program is a game changer for patients and providers. The rapid adoption of the Direct Purchase Program demonstrated to OrthogenRx that we are meeting a true unmet need and making a difference.”

“OrthogenRx understands the complexities of Orthopedics; navigating the changes in  health care dynamics is challenging and burdensome. OrthogenRx is committed to minimizing disruptions and providing turnkey solutions: From product acquisition through reimbursement, we work in lockstep with your team to ensure your patients get the pain relief they need. OrthogenRx is consistently listening to the voice of the customer to identify areas in which we can improve and innovate to exceed their expectations.”